Corrigendum: Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma.

Frontiers in Pharmacology(2024)

引用 0|浏览6
暂无评分
摘要
[This corrects the article DOI: 10.3389/fphar.2023.1124214.].
更多
查看译文
关键词
hepatocellular carcinoma,cytochrome P450,sorafenib,EET,EDP,omega-3 fatty acids
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要